Spero Therapeutics rating maintained at Buy by HC Wainwright
HC Wainwright & Co. maintained its Buy rating on Spero Therapeutics, per Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.